Navigation Links
Epigenetic and MicroRNA Biomarkers 2013 Market Report
Date:8/8/2013

DUBLIN, August 8, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/tx3prw/epigenetic_and) have announced the addition of the "Epigenetic and MicroRNA Biomarkers 2013 Market Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

This market report represents the most up-to-date analysis of the Epigenetic and MicroRNA Biomarkers spaces together with research market data [qualitative and quantitative analysis] characterizing the epigenetics and microRNA research fields.

The epigenetic and microRNA biomarkers fields are co-evolving and have reached a critical point wherein enough signatures have been identified across various different disease classes, most notably in cancer, that some of these signatures/expression patterns can be validated and deployed for use in the clinic. However, these biomarker fields are evolving in parallel with the research marketplace, and therefore the authors have in this market report characterized the research markets for both these fields so as to present a comprehensive analysis that en bloc provides a complete picture of this expanding marketplace.

Key Topics Covered

Epigenetics Research Market Analysis

- Primary Market Survey to Characterize Research Market Trends based on Data Collected from Researchers
- Breakout of Epigenetics Research Activity based on Epigenetic Modifications Studied
- Segmentation of Epigenetics Research Activity based on Disease Classes Studied
- Epigenetics Research Activity in Cancer--Quantitative Segmentation
- Reagent Kits and Products in the Epigenetics Research Field [Details of Products from the Vendors in this Space are Presented and Analyzed]

Epigenetics Biomarkers

- En masse Analysis of All Epigenetics-focused Publications and Trends from these Data with respect to Potential Epigenetics Biomarkers
- Description of Epigenetic Biomarkers Identified to Date in Various Cancer Classes [Nature of Epigenetic Signature, Potential Role in Prognostics and Diagnostics]

MicroRNA Research Market Analysis

- Primary Market Survey Data Presents a Complete Picture of the microRNA Research Field based on End-User/Researcher Practices
- Methodologies and Market Breakout for Expression Profiling
- Quantitative Breakout of the microRNA Research Market Across the Research Workflow
- Product Vendors and their Quantitative Penetrance in the microRNA Research Markets

MicroRNA Biomarkers Analysis

- Expression Patterns/Signatures of microRNAs in Different Disease States
- Prognostic/Diagnostic Potential of microRNA Expression Patterns
- microRNAs in Biological Fluids as Circulating Biomarkers: List and Significance

Cancer Biomarker Classes

- Traditional Cancer Biomarkers
- Oncogenes
- Tumor-Suppressor Genes

Companion Diagnostics (CDx)

- Up-to-date List of CDx on the Marketplace
- Partnerships in the CDx Space 

For more information visit http://www.researchandmarkets.com/research/tx3prw/epigenetic_and

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Epigenetics Holds Key to Healthier Future
2. NIH Awards New England Biolabs a Phase II SBIR Grant for the Research and Development of Novel Enzymes for Epigenetic Studies
3. GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
4. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
5. Epigenetics: Changing the Way We Think about DNA
6. GeneTex Introduces New Mouse Monoclonal Antibody Against the Ten-Eleven Translocation 1 (TET1) Protein for DNA Methylation/Epigenetics Research
7. RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response
8. BellBrook Labs and Tecan Offer Webinar on Screening Epigenetic Targets
9. OvaGene Oncology Collaborates With Moffitt Cancer Center to Develop and Commercialize microRNAs Associated With Chemotherapeutic Drug Response
10. ResearchMoz: MicroRNA Market Trends 2011
11. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, ... and biotechnology industries to improve patient outcomes and quality of life, will now ... testing are being attributed to new regulatory requirements for all new drug products, ...
(Date:10/11/2017)... ... 11, 2017 , ... At its national board meeting in ... Sheikh, the co-founder, CEO and chief research scientist of Minnesota-based Advanced Space Technology ... in ARCS Alumni Hall of Fame . ASTER Labs is a technology ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for ... time. So which eye do you rinse first if a dangerous substance enters both eyes? ... Eye Wash with its unique dual eye piece. , “Whether its dirt and debris, ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):